EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, DECEMBER 17, 2012
Media Advisory: To contact author Christopher M. Johnson, M.D., call Sonja Hanson 619-532-9380 or firstname.lastname@example.org.
CHICAGO – The annual economic burden of pediatric caustic ingestion injuries was estimated at nearly $23 million with an estimated prevalence of injuries requiring hospitalization for 807 children in 2009, according to a report in the December issue of Archives of Otolaryngology – Head & Neck Surgery, a JAMA Network publication.
Although not well documented, the prevalence of caustic ingestion injuries appears to have decreased over the years through legislative measures, including requiring the labeling of caustic substances such as lye. Having epidemiologic data is necessary to analyze the effect of legislative measures and to investigate national trends and variations to develop new prevention strategies, according to the study background.
Christopher M. Johnson, M.D., and Matthew T. Brigger, M.D., M.P.H., of the Naval Medical Center, San Diego, used the 2009 Kids’ Inpatient Database to generate national estimates of the public health burden related to caustic injury. The authors estimated that the prevalence of pediatric caustic ingestion injuries requiring hospitalization in 2009 to be 807 children.
“Based on the weighted estimate, the prevalence of pediatric caustic ingestion injuries in the United States during 2009 appears to be much lower than the figure widely stated in the literature. The finding of a decreased prevalence of caustic injuries makes sense given the public health interventions currently in place,” the authors comment.
The authors note that children with caustic ingestion injuries were estimated to incur hospital charges of nearly $23 million and account for more than 3,300 inpatient days.
“Further investigation is necessary to better define specific populations and to identify opportunities for targeted public health intervention,” the authors conclude.
(Arch Otolaryngol Head Neck Surg. 2012;138:1111-1115. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email email@example.com.